TREATMENT OF GOOD-RISK, STAGE-II, NONSEMINOMATOUS TESTIS CANCER

被引：2

作者：

BOSHOFF, C

RUSTIN, G

BEGENT, R

OLIVER, T

NEWLANDS, E

HOLDEN, L

ONG, J

机构：

[1] CHARING CROSS HOSP,DEPT MED ONCOL,LONDON W6 8RF,ENGLAND

[2] ROYAL FREE HOSP,ACAD DEPT ONCOL,LONDON NW3 2QG,ENGLAND

来源：

LANCET | 1994年 / 344卷 / 8929期

关键词：

D O I：

10.1016/S0140-6736(94)91740-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1085 / 1086

页数：2

共 5 条

[1]

BOSHOFF C, 1994, P ASCO

[2] PRIMARY CHEMOTHERAPY FOR STAGE-II NONSEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS [J].

HORWICH, A ;

NORMAN, A ;

FISHER, C ;

HENDRY, WF ;

NICHOLLS, J ;

DEARNALEY, DP .

JOURNAL OF UROLOGY, 1994, 151 (01) :72-77

[3] RISK OF BILATERAL TESTICULAR GERM-CELL CANCER IN DENMARK - 1960-1984 [J].

OSTERLIND, A ;

BERTHELSEN, JG ;

ABILDGAARD, N ;

HANSEN, SO ;

HJALGRIM, H ;

JOHANSEN, B ;

MUNCKHANSEN, J ;

RASMUSSEN, LH .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (19) :1391-1395

[4] NO INCREASE IN 2ND TUMORS AFTER CYTO-TOXIC CHEMOTHERAPY FOR GESTATIONAL TROPHOBLASTIC TUMORS [J].

RUSTIN, GJS ;

RUSTIN, F ;

DENT, J ;

BOOTH, M ;

SALT, S ;

BAGSHAWE, KD .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (09) :473-476

[5]

SHAMBERGER RC, 1981, CANCER TREAT REP, V65, P739

← 1 →